Download | < Back |
26 Mar 2024 | |
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we wish to inform that, Ethiopian FDA has conducted audit of Oncology Plant, Haridwar. We are awaiting the plant approval from FDA. Meanwhile we have submitted dossiers for 10 oncology products in Ethiopia. Kindly take the same on your record and oblige. | |
View all announcements for MEDICAMEN BIOTECH LTD. | Source: BSE India |